Spectrum Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC